Alzai Health (TSXV:ALZI) Shareholder Yield % : 0.00% (As of Jan. 2026)


TSXV:ALZI Alzai Health Corp TSXV:ALZI
9 GF Score
Price C$0.50
! 1 Warning Sign
View Full Analysis

What is Alzai Health Shareholder Yield %?

Alzai Health TSXV:ALZI 9 Shareholder Yield % is 0.00% as of Jan. 2026. GuruFocus rates TSXV:ALZI with a GF Score™ of 9/100. The stock has 1 warning sign investors should review. Among 1,300 Biotechnology companies, Alzai Health ranks worse than 76923% on this metric.

Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return. Alzai Health does not have enough data to calculate Shareholder Yield %.


Alzai Health  (TSXV:ALZI) Shareholder Yield % Explanation

Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."

Shareholder Yield % is calculated by three components: Dividend Yield %, Buyback Yield %, and Net Debt Paydown Yield %.

Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.

Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.

Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.


Alzai Health Shareholder Yield % Related Terms


Alzai Health Shareholder Yield % Historical Data

* Premium members only.

The historical data trend for Alzai Health's Shareholder Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alzai Health Shareholder Yield % Chart

Alzai Health Annual Data
Trend
Shareholder Yield %

Alzai Health Quarterly Data
Jan25 Apr25 Jul25 Oct25 Jan26
Shareholder Yield % 0.00 0.00 0.00 0.00 0.00

TSXV:ALZI vs VRTX, REGN, ALNY: Shareholder Yield % Comparison

For the Biotechnology subindustry, Alzai Health's Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alzai Health Shareholder Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alzai Health's Shareholder Yield % distribution charts can be found below:

* The bar in red indicates where Alzai Health's Shareholder Yield % falls into.


TSXV:ALZI
9GF Score
Alzai Health Corp TSXV:ALZI
Shareholder Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alzai Health Shareholder Yield % Calculation

Alzai Health's Shareholder Yield % for the quarter that ended in Jan. 2026 is calculated as:

Shareholder Yield %=Dividend Yield %+Buyback Yield %+Net Debt Paydown Yield %
=0.00 %+0 %+ %
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.

Frequently Asked Questions Learn more about Shareholder Yield % →
What does a Shareholder Yield % of 0.00% mean?
Alzai Health (TSXV:ALZI) has a Shareholder Yield % of 0.00% as of Jan. 2026. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Alzai Health and its competitors. According to the industry distribution chart, Alzai Health ranks #999999 out of 1300 companies in the Biotechnology industry.
Is Alzai Health's Shareholder Yield % too high?
Alzai Health's current Shareholder Yield % is 0.00%. Based on the distribution chart, Alzai Health ranks #999999 out of 1300 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Alzai Health has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Alzai Health's Shareholder Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Alzai Health ranks #999999 out of 1300 companies for Shareholder Yield %. This places Alzai Health in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for a Biotechnology company?
A good Shareholder Yield % depends on the Biotechnology industry context. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Alzai Health and its competitors. Alzai Health's current Shareholder Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alzai Health stock overvalued right now?
Alzai Health (TSXV:ALZI) has a current Shareholder Yield % of 0.00%. The current Shareholder Yield % is 0.00%. Alzai Health's overall GF Score™ is 9/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For Alzai Health (TSXV:ALZI), the current Shareholder Yield % is 0.00% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alzai Health Business Description

Address 22 Adelaide Street West, Suite 3400, Toronto, ON, CAN, M5H 4E3
Alzai Health Corp is a healthcare company focused on comprehensive health solutions. It is an AI-driven Alzheimer's disease risk screening platform, enabling disease prevention and early disease diagnosis to improve patient outcomes. The company uses low-cost, non-invasive, pre-existing biomarker data present in nearly all Electronic Medical Records of the relevant age demographic. It aims to address the unmet need in Alzheimer's screening, enabling early detection and mitigation driving to diagnosis, therapy or prevention.
9GF Score

Get the complete analysis for TSXV:ALZI

Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.50
Price